IFNB1 and myeloid sarcoma: In contrast to peripherally applied IFN-β in MS, for which mechanism is reviewed in [30], the effect of endogenous Type I IFN is a priori unlikely to involve inhibition of leukocyte infiltration, as supported by our data showing no effect on either histologically or flow cytometrically detected infiltration.